Aliases & Classifications for Oligohydramnios

Aliases & Descriptions for Oligohydramnios:

Name: Oligohydramnios 12 29 52 42 14 69
Oligohydramnios - Delivered 12 69
Oligohydramnios, Antepartum Condition or Complication 69
Antepartum Oligohydramnios 12
Delivered Oligohydramnios 12

Classifications:



External Ids:

Disease Ontology 12 DOID:12215
ICD10 33 O41.0 O41.00
ICD9CM 35 658.0
MeSH 42 D016104
NCIt 47 C92839
UMLS 69 C0079924

Summaries for Oligohydramnios

Disease Ontology : 12 A placenta disease that is characterized by a deficiency of amniotic fluid sometimes resulting in an embryonic defect through adherence between embryo and amnion.

MalaCards based summary : Oligohydramnios, also known as oligohydramnios - delivered, is related to potter's syndrome and renal tubular dysgenesis, and has symptoms including morning sickness An important gene associated with Oligohydramnios is AFP (Alpha Fetoprotein), and among its related pathways/superpathways are Nanog in Mammalian ESC Pluripotency and Peptide hormone metabolism. The drugs Warfarin and Vitamin E have been mentioned in the context of this disorder. Affiliated tissues include lung, placenta and kidney, and related phenotypes are behavior/neurological and growth/size/body region

Wikipedia : 71 Oligohydramnios is a condition in pregnancy characterized by a deficiency of amniotic fluid. It is the... more...

Related Diseases for Oligohydramnios

Diseases related to Oligohydramnios via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 134)
id Related Disease Score Top Affiliating Genes
1 potter's syndrome 11.8
2 renal tubular dysgenesis 11.2
3 twin-to-twin transfusion syndrome 11.1
4 bilateral renal agenesis dominant type 10.9
5 urethral obstruction sequence 10.8
6 situs inversus totalis with cystic dysplasia of kidneys and pancreas 10.8
7 multiple pterygium syndrome, lethal type 10.7
8 polycystic kidney and hepatic disease 10.7
9 meckel syndrome 1 10.7
10 potter syndrome type 1 10.7
11 trisomy 2 mosaicism 10.7
12 hypotrichosis simplex 10.3 ACE REN
13 hyperinsulinemic hypoglycemia, familial, 3 10.3 ACE REN
14 carbohydrate metabolic disorder 10.3 ACE REN
15 hypothyroidism, congenital nongoitrous, 5 10.2 ACE REN
16 hypogonadism mitral valve prolapse mental retardation 10.2 ACE REN
17 listeriosis 10.2 ACE REN
18 dientamoebiasis 10.2 ACE REN
19 congenital nystagmus 10.2 ACE REN
20 kidney leiomyosarcoma 10.2 AQP1 AQP3
21 penile cancer, childhood 10.2 ACE AGT
22 polyhydramnios 10.2
23 prediabetes syndrome 10.2 AQP1 AQP3
24 hypoaldosteronism, congenital, due to cmo i deficiency 10.2 AGT REN
25 paraurethral gland cancer 10.2 AFP CHRNG
26 impetigo 10.2 AFP AQP1 AQP3
27 chylocele of tunica vaginalis 10.1 ACE REN
28 angelucci's syndrome 10.1 AFP PKHD1
29 schizotypal personality disorder 10.1 ACE AGT REN
30 ceroid lipofuscinosis, neuronal, kufs type, adult onset 10.1 ACE AGT REN
31 capillary hemangioma 10.1 AFP PKHD1 REN
32 chronic myocardial ischemia 10.1 ACE AGT REN
33 myopia 10.1 ACE REN
34 malignant hyperthermia susceptibility 1 10.1 ACE AGT
35 petrositis 10.0 ACE AGTR1 REN
36 lymphadenitis 10.0 ACE AGTR1 REN
37 clear cell adenocarcinoma 10.0 ACE AGTR1 REN
38 mixed germ cell-sex cord neoplasm 10.0 ACE AGTR1 REN
39 mental retardation hypocupremia hypobetalipoproteinemia 10.0 AGT AGTR1
40 familial nasal acilia 10.0 AGT AGTR1 REN
41 calcinosis 10.0 ACE AGTR1 REN
42 cervix small cell carcinoma 10.0 ACE AGTR1 REN
43 critical limb ischemia 10.0 ACE AGTR1 REN
44 joint disorders 10.0 ACE AGTR1
45 preaxial polydactyly of fingers 10.0 ACE AGT AGTR1
46 eye degenerative disease 10.0 ACE AGT AGTR1
47 cetp-related hyperalphalipoproteinemia 10.0 ACE AGT AGTR1
48 aplasia cutis congenita recessive 10.0 ACE AGT AGTR1
49 agammaglobulinemia 6 10.0 ACE AGT AGTR1
50 laryngostenosis 10.0 ACE AGT AGTR1

Graphical network of the top 20 diseases related to Oligohydramnios:



Diseases related to Oligohydramnios

Symptoms & Phenotypes for Oligohydramnios

UMLS symptoms related to Oligohydramnios:


morning sickness

MGI Mouse Phenotypes related to Oligohydramnios:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.06 AGT AGTR1 AQP1 AQP3 CHRNA1 CHRNG
2 growth/size/body region MP:0005378 9.92 CHRNG PKHD1 REN ACE AGT AGTR1
3 cardiovascular system MP:0005385 9.91 ACE AGT AGTR1 AQP1 AQP3 PKHD1
4 homeostasis/metabolism MP:0005376 9.86 ACE AFP AGT AGTR1 AQP1 AQP3
5 mortality/aging MP:0010768 9.85 ACE AFP AGT AGTR1 AQP1 AQP3
6 renal/urinary system MP:0005367 9.5 ACE AGT AGTR1 AQP1 AQP3 PKHD1
7 reproductive system MP:0005389 9.1 ACE AFP AGT AQP1 PKHD1 REN

Drugs & Therapeutics for Oligohydramnios

Drugs for Oligohydramnios (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 73)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Warfarin Approved Phase 4 81-81-2 6691 54678486
2
Vitamin E Approved, Nutraceutical, Vet_approved Phase 4 59-02-9 14985
3 Vitamins Phase 4
4 Anticoagulants Phase 4
5 Coagulants Phase 4
6 Antioxidants Phase 4,Phase 2,Phase 3
7 Protective Agents Phase 4,Phase 2,Phase 3
8 Tocopherols Phase 4
9 Tocotrienols Phase 4
10
Coumarin Nutraceutical Phase 4 91-64-5 323
11 Omega 3 Fatty Acid Nutraceutical Phase 4
12 Tocopherol Nutraceutical Phase 4
13 Tocotrienol Nutraceutical Phase 4
14
Dinoprostone Approved Phase 3 363-24-6 5280360
15
Isosorbide Dinitrate Approved Phase 2, Phase 3 87-33-2 6883
16
Nitric Oxide Approved Phase 2, Phase 3 10102-43-9 145068
17
Oxytocin Approved, Vet_approved Phase 3 50-56-6 439302 53477758
18 Oxytocics Phase 3
19 Anti-Asthmatic Agents Phase 2, Phase 3
20 Autonomic Agents Phase 2, Phase 3
21 Bronchodilator Agents Phase 2, Phase 3
22 diuretics Phase 2, Phase 3
23 Endothelium-Dependent Relaxing Factors Phase 2, Phase 3
24 Isosorbide Phase 2, Phase 3
25 isosorbide-5-mononitrate Phase 2, Phase 3
26 Natriuretic Agents Phase 2, Phase 3
27 Neurotransmitter Agents Phase 2, Phase 3
28 Nitric Oxide Donors Phase 2, Phase 3
29 Peripheral Nervous System Agents Phase 2, Phase 3
30 Respiratory System Agents Phase 2, Phase 3
31 Vasodilator Agents Phase 2, Phase 3
32 Chelating Agents Phase 3
33
Misoprostol Approved 59122-46-2 5282381
34
Menthol Approved 2216-51-5 16666
35
Pertuzumab Approved 145040-37-5, 380610-27-5 2540
36
Trastuzumab Approved, Investigational 180288-69-1 9903
37
Estradiol Approved, Investigational, Vet_approved 50-28-2 5757 53477783
38
Indomethacin Approved, Investigational 53-86-1 3715
39
Cholecalciferol Approved, Nutraceutical 67-97-0 6221 10883523 5280795
40
Ergocalciferol Approved, Nutraceutical 50-14-6 5280793
41 Bone Density Conservation Agents
42 Calcium, Dietary
43 Ergocalciferols
44 Micronutrients
45 Trace Elements
46 vitamin d
47 Liver Extracts
48 Antacids
49 Anti-Ulcer Agents
50 Gastrointestinal Agents

Interventional clinical trials:

(show all 24)
id Name Status NCT ID Phase
1 Active Induction of Labor in Pregnancies Complicated With Oligohydramnios at Term Completed NCT02581774 Phase 4
2 Warfarine in Unexplained Oligohydramnios Completed NCT01569035 Phase 4
3 Role of Antioxidants in Unexplained Oligohydramnios,A Randomized Trial Completed NCT01990690 Phase 4
4 Amnioinfusion Initiative Unknown status NCT00787163 Phase 3
5 Induction of Labor in Oligohydramnios Unknown status NCT00815542 Phase 3
6 Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses Unknown status NCT00127946 Phase 3
7 Nitric Oxide Donors for Treatment of Isolated Oligohydramnios Completed NCT02712125 Phase 2, Phase 3
8 Mechanical cervicAl ripeninG for Women With PrOlongedPregnancies Recruiting NCT02907060 Phase 3
9 Stepwise Labor Induction Following Failure of Prostaglandin Vaginal Insert for Labor Induction Not yet recruiting NCT02684305 Phase 3
10 Alterations of the Uteroplacental and Fetal Pulmonary Circulation Following Amnioinfusion Unknown status NCT01258725 Phase 1
11 Vitamin D Treatment and Hypocalcemic Pregnant Women Unknown status NCT02021864
12 A Screening Strategy for Q Fever Among Pregnant Women Unknown status NCT01095328
13 İs There a Relationship Between Severity of Preeclampsia and Maternal Heavy Metal Levels? Unknown status NCT01906567
14 Studying Fetal Breathing Patterns Completed NCT00066976
15 Foley Catheter Versus Vaginal Misoprostol for Cervical Ripening and Induction of Labor Completed NCT01140971
16 Perinatal Outcome After Premature Rupture of Membranes Completed NCT01538030
17 Functional Capacity After Computer Assisted Periacetabular Osteotomy in Patients With Hip Dysplasia Completed NCT02015247
18 Fetal Renal Artery Doppler Indices in Borderline Isolated Oligohydramnios Recruiting NCT02901340
19 Sildenafil Citrate Therapy for Oligohydramnios Recruiting NCT02372487
20 PPROM Registry (Preterm Premature Rupture of Membranes) Recruiting NCT02997345
21 Renal Agenesis Fetal Therapy Recruiting NCT03101891
22 A Study of Pregnancy and Pregnancy Outcomes in Women With Breast Cancer Treated With Trastuzumab, Pertuzumab in Combination With Trastuzumab, or Ado-Trastuzumab Emtansine Recruiting NCT00833963
23 Indomethacin PK and PD Therapy in Pregnancy Recruiting NCT02451228
24 Hydrotherapy for the Reversal of Oligohydramnios Terminated NCT01682928

Search NIH Clinical Center for Oligohydramnios

Cochrane evidence based reviews: oligohydramnios

Genetic Tests for Oligohydramnios

Genetic tests related to Oligohydramnios:

id Genetic test Affiliating Genes
1 Oligohydramnios 29

Anatomical Context for Oligohydramnios

MalaCards organs/tissues related to Oligohydramnios:

39
Lung, Placenta, Kidney, Fetal Lung, Heart, Brain, Cervix

Publications for Oligohydramnios

Articles related to Oligohydramnios:

(show top 50) (show all 451)
id Title Authors Year
1
Oligohydramnios and growth restriction do not portend worse prognosis in gastroschisis pregnancies. ( 26932657 )
2016
2
Lack of pharmacist-physician communication associated with nimesulide-induced oligohydramnios during pregnancy. ( 26951121 )
2016
3
Oligohydramnios in complicated and uncomplicated pregnancies: a systematic review and meta-analysis. ( 27062200 )
2016
4
Induction of Labor in Women with Oligohydramnios: Misoprostol Compared with Prostaglandin E2. ( 27398704 )
2016
5
Pulmonary Hypoplasia Induced by Oligohydramnios: Findings from Animal Models and a Population-Based Study. ( 27324123 )
2016
6
Are Major Depression and Generalized Anxiety Disorder Associated With Oligohydramnios in Pregnant Women? A Case-Control Study. ( 27357862 )
2016
7
Significance of oligohydramnios in preterm small-for-gestational-age infants for outcome at 18 months of age. ( 27352940 )
2016
8
EP16.18: Outcome of the patients with late second trimester isolated oligohydramnios and echogenic bowel without evidence of premature rupture membranes. ( 27644197 )
2016
9
Role of l-Arginine in Oligohydramnios. ( 27651617 )
2016
10
Aquaporin 3 Expression Induced by Salvia Miltiorrhiza via ERK1/2 Signal Pathway in the Primary Human Amnion Epithelium Cells from Isolated Oligohydramnios. ( 26917259 )
2016
11
Obstetric outcomes of isolated oligohydramnios during early-term, full-term and late-term periods and determination of optimal timing of delivery. ( 27225520 )
2016
12
Prostaglandin E2 induction of labor and cervical ripening for term isolated oligohydramnios in pregnant women with Bishop scoreA a8oA 5. ( 27745800 )
2016
13
Use of an Amnioport to Maintain Amniotic Fluid Volume in Fetuses with Oligohydramnios Secondary to Lower Urinary Tract Obstruction or Fetal Renal Anomalies. ( 27287190 )
2016
14
Sildenafil citrate for the management of fetal growth restriction and oligohydramnios. ( 27563258 )
2016
15
Survival of fetuses with severe oligohydramnios. ( 27328487 )
2016
16
Isolated Oligohydramnios at Term as an Indication for Labor Induction: A Systematic Review and Meta-Analysis. ( 27160748 )
2016
17
A randomized controlled study of the efficacy of 4 weeks of supplementation with I8-3 polyunsaturated fatty acids in cases of unexplained oligohydramnios. ( 27559716 )
2016
18
Important clinical information from successful treatment of a case with isolated severe oligohydramnios and deficient fetal growth late in the second trimester. ( 26384073 )
2015
19
Outcomes and management strategies in pregnancies with early onset oligohydramnios. ( 26152010 )
2015
20
Feasibility and preliminary outcomes of fetoscopic laser photocoagulation for monochorionic twin gestation with selective intrauterine growth restriction accompanied by severe oligohydramnios. ( 26369752 )
2015
21
An Update on Maternal Hydration Strategies for Amniotic Fluid Improvement in Isolated Oligohydramnios and Normohydramnios: Evidence from a Systematic Review of Literature and Meta-Analysis. ( 26658482 )
2015
22
Placental lesions associated with oligohydramnios in fetal growth restricted (FGR) pregnancies. ( 25735841 )
2015
23
Reversible oligohydramnios in the second trimester of pregnancy in two patients with long-term diclofenac exposure. ( 26318712 )
2015
24
What does fetal autopsy unmask in oligohydramnios? ( 26381033 )
2015
25
Short-Term and Long-Term Postnatal Outcomes of Expectant Management After Previable Preterm Premature Rupture of Membranes With and Without Persistent Oligohydramnios. ( 26444125 )
2015
26
Perinatal outcomes with isolated oligohydramnios at term pregnancy. ( 26506098 )
2015
27
Intra-vaginal prostaglandin E2 versus double-balloon catheter for labor induction in term oligohydramnios. ( 25275693 )
2014
28
Maternal hydration therapy improves the quantity of amniotic fluid and the pregnancy outcome in third-trimester isolated oligohydramnios. ( 24764350 )
2014
29
The association between isolated oligohydramnios at term and pregnancy outcome. ( 24925346 )
2014
30
Perinatal outcomes in pregnancies with oligohydramnios after preterm premature rupture of membranes. ( 25283853 )
2014
31
Oligohydramnios in women with preterm prelabor rupture of membranes and adverse pregnancy and neonatal outcomes. ( 25171293 )
2014
32
Oligohydramnios sequence revisited in relationship to arthrogryposis, with distinctive skin changes. ( 25160497 )
2014
33
Severe midtrimester oligohydramnios: treatment strategies. ( 24614021 )
2014
34
Which is the safer method of labor induction for oligohydramnios women? Transcervical double balloon catheter or dinoprostone vaginal insert. ( 24397441 )
2014
35
Adverse perinatal and neonatal outcomes in patients with chronic abruption-oligohydramnios sequence. ( 24888925 )
2014
36
Oligohydramnios in a pregnant Pakistani woman with Plasmodium vivax malaria. ( 24758193 )
2014
37
Therapeutic amnioinfusion for chronic abruption-oligohydramnios sequence: A possible prevention of the infant respiratory disease. ( 24428672 )
2014
38
Decrease of the incidence of renin-angiotensin-system inhibitor induced oligohydramnios-sequence in Germany in 2011. ( 24633976 )
2014
39
Predictive value of second and third trimester fetal renal artery Doppler indices in idiopathic oligohydramnios and polyhydramnios in low-risk pregnancies: A longitudinal study. ( 25363086 )
2014
40
Transabdominal amnioinfusion for improving fetal outcomes after oligohydramnios secondary to preterm prelabour rupture of membranes before 26 weeks. ( 23913522 )
2013
41
Oligohydramnios increases the risk of respiratory hospitalization in childhood: a population-based study. ( 24366513 )
2013
42
Prenatal diagnosis of mosaic trisomy 2 associated with abnormal maternal serum screening, oligohydramnios, intrauterine growth restriction, ventricular septal defect, preaxial polydactyly, and facial dysmorphism. ( 24075380 )
2013
43
Perinatal outcomes of isolated oligohydramnios at term and post-term pregnancy: a systematic review of literature with meta-analysis. ( 23561019 )
2013
44
Applicability of fetal renal artery Doppler values in determining pregnancy outcome and type of delivery in idiopathic oligohydramnios and polyhydramnios pregnancies. ( 24455852 )
2013
45
Breech repositioning unresponsive to Webster technique: coexistence of oligohydramnios. ( 24294149 )
2013
46
Fetal swallowing as a protective mechanism against oligohydramnios and polyhydramnios in late gestation sheep. ( 22872543 )
2013
47
Effects of maternal retinoic acid administration on lung angiogenesis in oligohydramnios-exposed fetal rats. ( 23590952 )
2013
48
Female pseudohermaphroditism in a prenatally diagnosed cloacal malformation with hydronephrosis, dilated bladder, hydrometrocolpos, and oligohydramnios. ( 24411046 )
2013
49
Amnioinfusion before 26 weeks' gestation for severe fetal growth restriction with oligohydramnios: Preliminary pilot study. ( 24245667 )
2013
50
The protective effect of oligohydramnios in a case of missed diagnosis of spontaneous septostomy in monochorionic diamniotic twins. ( 23445154 )
2013

Variations for Oligohydramnios

ClinVar genetic disease variations for Oligohydramnios:

6
id Gene Variation Type Significance SNP ID Assembly Location
1 TMEM67 NM_153704.5(TMEM67): c.1843T> C (p.Cys615Arg) single nucleotide variant Pathogenic/Likely pathogenic rs201893408 GRCh37 Chromosome 8, 94808198: 94808198
2 PKHD1 NM_138694.3(PKHD1): c.107C> T (p.Thr36Met) single nucleotide variant Pathogenic,protective rs137852944 GRCh37 Chromosome 6, 51947999: 51947999
3 TMEM67 NM_153704.5(TMEM67): c.1321C> T (p.Arg441Cys) single nucleotide variant Pathogenic/Likely pathogenic rs752362727 GRCh38 Chromosome 8, 93786255: 93786255

Expression for Oligohydramnios

Search GEO for disease gene expression data for Oligohydramnios.

Pathways for Oligohydramnios

GO Terms for Oligohydramnios

Cellular components related to Oligohydramnios according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 plasma membrane GO:0005886 9.61 ACE AGTR1 AQP1 AQP3 CHRNA1 CHRND
2 postsynaptic membrane GO:0045211 9.33 CHRNA1 CHRND CHRNG
3 acetylcholine-gated channel complex GO:0005892 8.8 CHRNA1 CHRND CHRNG

Biological processes related to Oligohydramnios according to GeneCards Suite gene sharing:

(show all 37)
id Name GO ID Score Top Affiliating Genes
1 excitatory postsynaptic potential GO:0060079 9.77 CHRNA1 CHRND CHRNG
2 regulation of blood pressure GO:0008217 9.76 ACE AGT REN
3 regulation of postsynaptic membrane potential GO:0060078 9.71 CHRNA1 CHRND CHRNG
4 blood vessel remodeling GO:0001974 9.67 ACE AGT
5 odontogenesis GO:0042476 9.67 AQP1 AQP3
6 renal water homeostasis GO:0003091 9.67 AQP1 AQP3
7 positive regulation of reactive oxygen species metabolic process GO:2000379 9.66 AGT AGTR1
8 positive regulation of protein tyrosine kinase activity GO:0061098 9.65 ACE AGT
9 neuromuscular process GO:0050905 9.65 CHRNA1 CHRND
10 skeletal muscle contraction GO:0003009 9.65 CHRNA1 CHRND
11 response to nicotine GO:0035094 9.65 CHRNA1 CHRND CHRNG
12 water transport GO:0006833 9.64 AQP1 AQP3
13 positive regulation of cellular protein metabolic process GO:0032270 9.64 AGT AGTR1
14 positive regulation of macrophage derived foam cell differentiation GO:0010744 9.63 AGT AGTR1
15 beta-amyloid metabolic process GO:0050435 9.63 ACE REN
16 regulation of vasodilation GO:0042312 9.62 ACE AGTR1
17 low-density lipoprotein particle remodeling GO:0034374 9.62 AGT AGTR1
18 cation transmembrane transport GO:0098655 9.62 AQP1 CHRNA1 CHRND CHRNG
19 regulation of blood vessel diameter GO:0097746 9.61 ACE AGTR1
20 positive regulation of cholesterol esterification GO:0010873 9.61 AGT AGTR1
21 neuromuscular synaptic transmission GO:0007274 9.61 CHRNA1 CHRND CHRNG
22 glycerol transport GO:0015793 9.6 AQP1 AQP3
23 musculoskeletal movement GO:0050881 9.58 CHRNA1 CHRND
24 synaptic transmission, cholinergic GO:0007271 9.58 CHRNA1 CHRND CHRNG
25 positive regulation of NAD(P)H oxidase activity GO:0033864 9.57 AGT AGTR1
26 regulation of renal sodium excretion GO:0035813 9.56 AGT AGTR1
27 renal water absorption GO:0070295 9.55 AQP1 AQP3
28 regulation of vasoconstriction GO:0019229 9.54 ACE AGT AGTR1
29 regulation of blood volume by renin-angiotensin GO:0002016 9.52 AGT REN
30 regulation of blood vessel diameter by renin-angiotensin GO:0002034 9.51 AGT AGTR1
31 skeletal muscle tissue growth GO:0048630 9.49 CHRNA1 CHRND
32 regulation of renal output by angiotensin GO:0002019 9.46 ACE AGT
33 angiotensin maturation GO:0002003 9.43 ACE AGT REN
34 regulation of systemic arterial blood pressure by renin-angiotensin GO:0003081 9.33 ACE AGT AGTR1
35 renin-angiotensin regulation of aldosterone production GO:0002018 9.13 AGT AGTR1 REN
36 kidney development GO:0001822 9.02 ACE AGT AGTR1 PKHD1 REN
37 transport GO:0006810 10.14 AFP AQP1 AQP3 CHRNA1 CHRND CHRNG

Molecular functions related to Oligohydramnios according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular ligand-gated ion channel activity GO:0005230 9.5 CHRNA1 CHRND CHRNG
2 ligand-gated ion channel activity GO:0015276 9.43 CHRNA1 CHRND CHRNG
3 acetylcholine receptor activity GO:0015464 9.4 CHRNA1 CHRNG
4 water channel activity GO:0015250 9.37 AQP1 AQP3
5 bradykinin receptor binding GO:0031711 9.16 ACE AGTR1
6 acetylcholine binding GO:0042166 9.13 CHRNA1 CHRND CHRNG
7 acetylcholine-gated cation-selective channel activity GO:0022848 8.8 CHRNA1 CHRND CHRNG

Sources for Oligohydramnios

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....